NeuroPace Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13.12	18.18	6.73	19.31	26.76	4.12
Short-Term Investments	45.95	48.4	70.8	96.4	11.69	0.97
Cash & Cash Equivalents	59.07	66.58	77.53	115.71	38.45	5.09
Cash Growth	-12.80%	-14.13%	-32.99%	200.97%	655.01%	-
Receivables	11.63	12.31	7.48	7.09	8.4	6.02
Inventory	11.42	11.21	9.71	7.82	6.91	7.9
Other Current Assets	2.14	2.62	2.99	2.2	0.81	1.25
Total Current Assets	84.25	92.72	97.71	132.82	54.56	20.26
Property, Plant & Equipment	14.08	14.41	15.9	0.6	0.52	0.81
Other Long-Term Assets	0.52	0.52	0.49	0.14	0.87	0.03
Total Long-Term Assets	14.6	14.93	16.39	0.75	1.39	0.84
Total Assets	98.85	107.65	114.11	133.56	55.95	21.1
Accounts Payable	3.27	2.33	2.15	1.38	0.95	0.9
Deferred Revenue	0.87	1.09	0	0	0	0
Current Debt	1.68	1.63	1.42	0	2.04	62.8
Other Current Liabilities	7.29	11.18	7.41	7.92	6.6	11.45
Total Current Liabilities	13.11	16.23	10.98	9.3	9.6	75.15
Long-Term Debt	71.4	70.77	68.35	49.85	50.82	0
Other Long-Term Liabilities	0	0	0	0.91	1.94	1.73
Total Long-Term Liabilities	71.4	70.77	68.35	50.76	52.77	1.73
Total Liabilities	84.51	87	79.33	60.06	62.36	76.88
Total Debt	73.09	72.4	69.77	49.85	52.86	62.8
Debt Growth	3.86%	3.77%	39.96%	-5.71%	-15.82%	-
Retained Earnings	-512.73	-503.81	-470.85	-423.77	-387.69	-363.64
Comprehensive Income	0	0	-1.11	-0.27	0.03	0
Shareholders' Equity	14.34	20.65	34.78	73.5	-147.83	-129.35
Net Cash / Debt	-14.02	-5.82	7.76	65.86	-14.42	-57.71
Net Cash / Debt Growth	-	-	-88.21%	-	-	-
Net Cash Per Share	-0.50	-0.23	0.32	3.97	-70.66	-285.78
Working Capital	71.14	76.49	86.74	123.52	44.97	-54.89
Book Value Per Share	0.51	0.80	1.41	4.43	-724.42	-640.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).